Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $7.3752W HIGH $25.12
Volume
11.00 M
Value Traded
81.73 M
Short % Float
12.41%
+9.7%Week
-33.15%1 Month
-56.08%3 Month
-57.51%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
1.81 B
EPS (TTM)
0.20
P/E Ratio
44.39
Ent. Value
1.43 B
Total Shares
207.39 M
Float Shares
198.35 M
Insiders
4.38%
Institutions
114.40%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
ALHC Catalyst Timeline
Dated clinical, regulatory and corporate events for Alignment Healthcare, Inc. Common Stock
Past FDA Catalysts and PDUFA Decisions
How ALHC actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Alignment Healthcare, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every ALHC program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Kim HyongOfficer (Chief Medical Officer) | Sell | -32,479 299,271 held | $8.30 | 10/06/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in ALHC
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.9 % (-13.6 %) | 47.62 M | 2.00 M | -22.33% ( -575.00 K) |
ALHC Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-12-18 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How ALHC ranks across every disease it competes in
Competitive Position is a premium feature
See how ALHC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialALHC News
-ALHC
Oct 8, 2026▼ -21.3%today
Alignment Healthcare Earns 4 Stars or Higher for Six of Seven Eligible Medicare Advantage Contracts in CMS 2027 Star Ratings
Alignment Healthcare announced that six of its seven eligible Medicare Advantage contracts received 4 stars or higher in the CMS 2027 Star Ratings, with three achieving a 4.5-Star Rating. However, the company's California H3815 HMO contract received a 3.5-Star Rating, which Alignment disputes. The company emphasizes the need for accurate quality measurement methodologies amid ongoing concerns in the industry.
Read more →-ALHC
Aug 20, 2026Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference
Alignment Healthcare, Inc. (NASDAQ: ALHC) will participate in two major healthcare conferences in New York. The company will present at the Baird 2026 Global Healthcare Conference on September 15 and attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 16. A webcast of the Baird presentation will be available online.
Read more →-ALHC
Jul 30, 2026▼ -20.2%on this news
Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics
Alignment Healthcare reported strong financial results for Q2 2026, with total revenue reaching $1.3 billion, marking a 31.6% increase year-over-year. The company also saw a significant growth in Medicare Advantage membership, which rose by 31.5% to approximately 294,100 members. Additionally, the company raised its full-year guidance across key metrics, indicating a positive outlook for the remainder of the year.
Read more →-ALHC
Jul 9, 2026Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) will announce its second quarter 2026 financial results on July 30, 2026, after market close. Following the announcement, a conference call will be held at 5 p.m. EDT to discuss the results. The company emphasizes its mission to provide high-quality, low-cost care for Medicare Advantage members.
Read more →-ALHC
Jun 2, 2026Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report
Alignment Healthcare's 2025 Impact Report highlights the success of its proactive care model, which has led to significant reductions in emergency room visits and hospital admissions. The report shows a commitment to improving member health through coordinated care and innovative technology. With 100% of plans rated 4 Stars or higher, Alignment continues to demonstrate high-quality performance in the Medicare Advantage sector.
Read more →-ALHC
May 18, 2026Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The event will take place in Miami, Florida, at 10:40 a.m. EDT. A webcast of the presentation will be accessible on the company's investor relations website.
Read more →-ALHC
May 12, 2026▲ +7.1%on this news
Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation
Alignment Healthcare has announced key leadership changes to enhance its growth strategy. Founder and CEO John Kao will also serve as Chairman of the Board, ensuring continuity in leadership. Industry veterans Mark Kent and Shane Hochradel join the team in critical roles to strengthen the management structure and operational execution. These changes are designed to support the company's expansion and commitment to long-term shareholder value creation.
Read more →-ALHC
Apr 9, 2026Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) will announce its first quarter 2026 financial results on April 30, 2026, after market close. Following the announcement, a conference call will be held at 5 p.m. EDT to discuss the results. The company emphasizes its commitment to providing quality care for Medicare Advantage members.
Read more →-ALHC
Apr 1, 2026Alignment Healthcare to Present at the BofA Securities Health Care Conference 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) will present at the BofA Securities Health Care Conference 2026 in Las Vegas on May 13. The webcast of the presentation will be available on their investor relations website. The company is committed to providing high-quality, low-cost care for Medicare Advantage members.
Read more →-ALHC
Feb 23, 2026Alignment Healthcare to Present at the Leerink Partners Global Healthcare Conference
Alignment Healthcare, Inc. (NASDAQ: ALHC) announced its participation in the Leerink Partners Global Healthcare Conference, scheduled for March 10 in Miami, Florida. The presentation will be available via webcast on the company's investor relations website. Alignment Healthcare emphasizes its commitment to enhancing senior care through innovative services and technology.
Read more →-ALHC
Feb 5, 2026Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) will announce its fourth quarter and full-year 2025 financial results on February 26, 2026. Following the announcement, a conference call will be held at 5 p.m. EST to discuss the results. The company focuses on providing quality care for Medicare Advantage members through a unique care model.
Read more →-ALHC
Jan 21, 2026Alignment Healthcare Named to the 2026 Fortune World’s Most Admired Companies™ List for First Time
Alignment Healthcare has made its debut on the 2026 Fortune World's Most Admired Companies list, reflecting its strong reputation in the Health Care: Insurance and Managed Care category. This recognition comes five years after the company went public and highlights its commitment to senior care. CEO John Kao attributes this achievement to the team's dedication and innovative approach to Medicare Advantage.
Read more →-ALHC
Jan 20, 2026Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership
Alignment Health has appointed Adnan Mansour as Chief Digital Officer, effective January 19, 2026. Mansour, who previously held a senior role at Optum Insight, will focus on scaling the company's digital capabilities and enhancing its AI-powered AVA platform. This strategic move comes as Alignment Health experiences substantial growth in its Medicare Advantage membership.
Read more →-ALHC
Jan 8, 2024▲ +13.2%on this news
Legal Disclaimer Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Ac
Alhambra Health Care (ALHC) has reported a substantial growth in membership, achieving a 44% year-over-year increase with 155,500 members as of January 1, 2024. This growth primarily stems from effective market strategies, particularly in California, and successful operational execution during the Annual Enrollment Period. The company also anticipates reaching Adjusted EBITDA breakeven in 2024, supported by enhanced member engagement and the implementation of the AVA technology platform. Looking forward, ALHC expects favorable conditions in 2025, aided by ongoing improvements and strategic investments.
Read more →-ALHC
May 17, 2021ALIGNMENT HEALTHCARE REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS ORANGE, Calif. (
ALIGNMENT HEALTHCARE REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS ORANGE, Calif. (May 17, 2021) Alignment Healthcare, Inc. ( Alignment Healthcare or the Company ) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today reported financial results for its
Read more →-ALHC
Mar 30, 2021ALIGNMENT HEALTHCARE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING ORANGE, Calif. (
ALIGNMENT HEALTHCARE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING ORANGE, Calif. (March 30, 2021) Alignment Healthcare, Inc. ( Alignment Healthcare or the Company ) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today announced the closing of its init
Read more →About Alignment Healthcare, Inc. Common Stock
Headquarters1100 W. TOWN AND COUNTRY ROAD, ORANGE, CA, 92868
BIOPHARMAWATCH ELITE PLUS
Trade the next ALHC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime